Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Classement en actions #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Prix de l'action
$154.51
Capitalisation boursière
$55.98B
Changement (1 jour)
-1.82%
Changement (1 an)
-32.08%
Pays
US
Échange Becton, Dickinson and Company (BDX)

Catégorie

Bénéfices pour Becton, Dickinson and Company (BDX)
Bénéfices en Dec 2025 TTM : $2.06B
Selon les derniers rapports financiers de Becton, Dickinson and Company, les bénéfices actuels de l'entreprise sont de $2.06B. En 2024, l'entreprise a réalisé un bénéfice de $2.01B, une augmentation par rapport à celui de 2023 qui était de $1.66B. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Becton, Dickinson and Company de 2000 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $2.06B 9.62%
2025 $1.88B -6.13%
2024 $2.01B 20.64%
2023 $1.66B -6.79%
2022 $1.78B 5.38%
2021 $1.69B 308.70%
2020 $414.00M -64.80%
2019 $1.18B 0.26%
2018 $1.17B 20.18%
2017 $976.00M -9.12%
2016 $1.07B 45.33%
2015 $739.00M -51.45%
2014 $1.52B 30.64%
2013 $1.17B -20.86%
2012 $1.47B -9.02%
2011 $1.62B 3.27%
2010 $1.57B -0.75%
2009 $1.58B 2.61%
2008 $1.54B 27.78%
2007 $1.20B 6.93%
2006 $1.13B 12.05%
2005 $1.00B 33.47%
2004 $752.87M 4.28%
2003 $721.96M 15.06%
2002 $627.47M 8.79%
2001 $576.75M 10.93%
2000 $519.93M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$3.31B 60.51%
US
$394.38M -80.88%
DE
$2.05B -0.80%
JP
$1.16B -43.77%
CH
$1.82B -11.84%
US